Loading...
Famotidine — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Famotidine
2025-Q4
Comprehensive analysis of India’s famotidine export trade — suppliers, buyers, prices, routes, and every shipment record.
246
Shipments
$4.37M
Trade Value
49
Suppliers
51
Buyers
28
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/famotidine
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s famotidine trade — 2025-Q4
KEY TAKEAWAY
Famotidine 2025-Q4 exports total $4.4M across 28 countries, with ALEMBIC PHARMACEUTICALS LTD commanding 27.1% market share.
TOTAL SHIPMENTS
246
2025-Q4
EXPORT VALUE
$4.4M
FOB USD
TOTAL QUANTITY
143.3M
units shipped
INDIAN SUPPLIERS
49
unique exporters
GLOBAL BUYERS
51
unique importers
DESTINATIONS
28
countries
MEDIAN UNIT PRICE
$0.137
per unit
TOP-5 SHARE
59.3%
of total USD
BRANDED SHARE
63.0%
155 shipments
DOSAGE FORMS
5
product types
6 KEY FINDINGS
1
ALEMBIC PHARMACEUTICALS LTD is India's #1 Famotidine exporter with $1.2M (27.1% market share).→ §5, Indian Supplier Rankings
2
Famotidine reached 28 countries, with United States as the top destination ($3.3M).→ §4, Global Destination Map
3
Market concentration is low (HHI: 1153) — top 10 suppliers control 78.1% of exports.→ §5, Indian Supplier Rankings
4
96.1% of buyers (49 of 51) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (68.6%) across 5 dosage forms.→ §7, Price Benchmarks
6
27 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 ALEMBIC PHARMACEUTICALS LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian famotidine exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Famotidine report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial famotidine trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian famotidine suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Famotidine India trade report
Product scope
Famotidine
All variants merged — branded and generic formulations of famotidine
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
246
Every commercial famotidine trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $1.2M, Nov $1.6M, Dec $1.5M. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$1.2M
Oct USD
51 shipments
2
$1.6M
Nov USD
+28.3% MoM
3
$1.5M
Dec USD
-4.1% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 28.3% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $1.2M, making it the weakest month by value.
Fig 3.2 Q4 cumulative USD reached $4.4M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $352K rise in Nov, $66K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $1.2M | 51 shipments |
| Nov | $1.6M | 113 shipments |
| Dec | $1.5M | 82 shipments |
| Q4 Total | $4.4M | 246 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: United States held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: ANNORA PHARMA PVT LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import famotidine from India, how much they buy, and who supplies each market
KEY TAKEAWAY
United States absorbs 74.9% of India’s 2025-Q4 famotidine trade ($3.3M). Beyond the top 10 destinations, 27 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 11 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 27 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much famotidine India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$591K
13.5% of trade
11 countries · 85 shipments
Europe
$176K
4.0% of trade
6 countries · 12 shipments
Americas
$3.5M
79.9% of trade
5 countries · 122 shipments
Africa
$38K
0.9% of trade
5 countries · 24 shipments
Oceania
$74K
1.7% of trade
1 countries · 3 shipments
Fig 4.1 United States is the #1 corridor ($3.3M) — 28 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian famotidine it receives (light = low, dark = high). Orange arcs radiate from India to the top 28 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | United States | $3.3M | 113 | ALEMBIC PHARMACEUTICALS LTD | $1.2M | MYLAN LABORATORIES LTD | $578K | ANNORA PHARMA PVT LTD | $387K |
| 2 | Turkmenistan | $219K | 5 | THRIVE THERAPEUTIC PVT LTD | $214K | PROTECH TELELINKS | $5K | CIAN HEALTHCARE LTD | $323 |
| 3 | Japan | $207K | 3 | MEDREICH LTD | $207K | — | — | — | — |
| 4 | Costa Rica | $188K | 2 | WALLACE PHARMACEUTICALS PVT LTD | $188K | — | — | — | — |
| 5 | Israel | $108K | 2 | MEDOPHARM | $108K | — | — | — | — |
| 6 | United Kingdom | $100K | 1 | UNISON PHARMACEUTICALS PVT LTD | $100K | — | — | — | — |
| 7 | Australia | $74K | 3 | CADILA PHARMACEUTICALS LTD | $74K | — | — | — | — |
| 8 | Nigeria | $24K | 1 | RATNATRIS PHARMACEUTICALS PVT LTD | $24K | — | — | — | — |
| 9 | France | $23K | 1 | AJANTA PHARMA LTD | $23K | — | — | — | — |
| 10 | Chile | $22K | 1 | ANNORA PHARMA PVT LTD | $22K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 13.5% of USD — but United States is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
74.9%
#1 country share
United States alone
91.4%
Top 5 share
5 of 28 countries
98.9%
Top 15 share
Long tail of 13 countries = 1.1%
HHI 5689
Destination HHI
Highly concentrated
28
Countries served
Global pharma reach from India
11
Asia countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
49 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
ALEMBIC PHARMACEUTICALS LTD ($1.2M, 27.1% share) and MYLAN LABORATORIES LTD ($578.0K) together control 40.3% of India’s 2025-Q4 famotidine trade. The top 5 suppliers hold 59.3%. 49 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian famotidine suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 ALEMBIC PHARMACEUTICALS LTD leads by $606K over MYLAN LABORATORIES LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: MARKSANS PHARMA LTD is #20 by value but #6 by volume.
Fig 5.2 ALEMBIC PHARMACEUTICALS LTD also leads by shipment count (26) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: MARKSANS PHARMA LTD moves from #6 by volume to #20 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 49 famotidine suppliers split into strategic segments
KEY TAKEAWAY
13 suppliers (25%) generate 84.8% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 ALEMBIC PHARMACEUTICALS LTD and MYLAN LABORATORIES LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 84.8% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | ANNORA PHARMA PVT LTD | 3 | 2 | $409K |
| 2 | ALEMBIC PHARMACEUTICALS LTD | 1 | 1 | $1.2M |
| 3 | MYLAN LABORATORIES LTD | 1 | 1 | $578K |
| 4 | THRIVE THERAPEUTIC PVT LTD | 1 | 1 | $214K |
| 5 | DRREDDYS LABORATORIES LTD | 1 | 1 | $211K |
| 6 | MEDREICH LTD | 1 | 1 | $207K |
| 7 | MAIVA PHARMA PVT LTD | 1 | 1 | $199K |
| 8 | WALLACE PHARMACEUTICALS PVT LTD | 1 | 1 | $188K |
| 9 | MEDOPHARM | 1 | 3 | $124K |
| 10 | LUPIN LTD | 1 | 1 | $102K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the famotidine manufacturing hubs
KEY TAKEAWAY
Gujarat and Bangalore together account for $1.7M of India’s 2025-Q4 famotidine trade.
Fig 5.5 Gujarat (1 exporters, $1.1M) and Bangalore (2 exporters, $672K) are India’s famotidine capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
59.3%
Top 5 share
5 of 49 suppliers
78.1%
Top 10 share
10 of 49 suppliers
84.8%
Top 25% share
13 suppliers = 85% USD
HHI 1153
Supplier HHI
Competitive
49
Total suppliers
shipped Famotidine in 2025-Q4
20+ cities
Indian hubs
Gujarat and Bangalore lead
§5.2 Coming next: 1 exporter deep-dive profiles
Each of the top 1 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | ANNORA PHARMA PVT LTD | $409K |
#3
EXPORTER PROFILE #1 OF 1
ANNORA PHARMA PVT LTD
Sangaredy District · India’s #3 famotidine supplier by USD · 2025-Q4
2025-Q4 USD
$409K
9.4% market share
SHIPMENTS
18
avg $23K/ship
COUNTRIES
2
destination markets
BUYERS
4
3 single-sourced
BRANDED
11%
of shipments
DOSAGE FORMS
3
product types
TOP 2 DESTINATIONS
United States is the #1 market at $387K (95% of trade), followed by Chile at $22K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | United States | $387K | 17 | 94.7% |
| 2 | Chile | $22K | 1 | 5.3% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $210K.
PRODUCT MIX
Tablet dominates at 59% of trade. Solution (26.4%) and Suspension are secondary formulations.
TOP BUYERS · 3/3 LOCKED IN
3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | United States | $334K | N/A |
| CAMBER PHARMACEUTICALS… | United States | $44K | ⚠ Locked |
| SEVEN PHARMA CHILE SPA | Chile | $22K | ⚠ Locked |
| CAMBER CONSUMER CARE INC | United States | $9K | ⚠ Locked |
#3
EXPORTER PROFILE #1 OF 1 — TRADE FLOW MAP
ANNORA PHARMA PVT LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P1.3 United States absorbs $387K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 3 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
51 importers across 28 countries — who is buying Indian famotidine and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 76.7% of total USD. 96% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian famotidine. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 J. KNIPPER & COMPANY is the #1 importer at $987K (22.6%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
96%
Single-source
49 buyers rely on exactly 1 Indian supplier
0%
Dual-source
0 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
4%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source famotidine from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
United States 5 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| J. KNIPPER & COMPANY | ALEMBIC PHARMACEUTIC… | $987K | $0.012 | Tablet |
| MYLAN INSTITUTIONAL INC | MYLAN LABORATORIES LTD | $578K | $6.782 | Injection |
| REED-LANE INC | DRREDDYS LABORATORIE… | $147K | $0.015 | Tablet |
| EVERSANA LIFE SCIENCE … | MAIVA PHARMA PVT LTD | $104K | $0.612 | Injection |
| UPS SUPPLY CHAIN SOLUT… | LUPIN LTD | $102K | $1.041 | Suspension |
Afghanistan 4 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| NAHEB HAMZA LTD | PROTECH BIO SYSTEMS … | $11K | $0.554 | Tablet |
| RAHMAN WALI LTD | ARBRO PHARMACEUTICAL… | $2K | $0.210 | Tablet |
| MUSBAH TASNIM TRADING … | ARBRO PHARMACEUTICAL… | $2K | $0.194 | Tablet |
| MUKBARAK HASHIMI LTD | CURETON BIOTECH PVT … | $271.710 | $0.055 | Tablet |
Seychelles 4 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| HEALTHCARE CARE AGENCY | D VIJAY PHARMA PVT LTD | $1K | $0.0044 | Tablet |
| MINISTRY OF HEALTH | HLL LIFECARE LTD | $199.659 | $0.0010 | Tablet |
| CAREWELL PHARMACY (PTY… | CHEMSELECT PVT LTD | $51.612 | $1.564 | Gel |
| PRISM INTERNATIONAL LLC | MEDMALL PHARMACY PVT… | $8.273 | $0.069 | Tablet |
Sri Lanka 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| PHARMA ASSOCIATES | LABORATE PHARMACEUTI… | $11K | $0.438 | Tablet |
| ALARIS LANKA (PVT) LTD | MEDOPHARM | $3K | $0.657 | Tablet |
Turkmenistan 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| SAGLYK E.S | PROTECH TELELINKS | $5K | $1.485 | Injection |
| MAIN PHARMACY ASSOCIAT… | CIAN HEALTHCARE LTD | $323.488 | $0.033 | Tablet |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | J. KNIPPER & COMPANY | United States | $987K | $45K | Premium |
| 2 | MYLAN INSTITUTIONAL … | United States | $578K | $34K | Mid |
| 3 | MEIJI SEIKA PHARMATE… | Japan | $207K | $69K | Premium |
| 4 | SEVEN PHARMA LTDA | Costa Rica | $188K | $94K | Premium |
| 5 | REED-LANE INC | United States | $147K | $73K | Premium |
| 6 | EVERSANA LIFE SCIENC… | United States | $104K | $52K | Premium |
| 7 | UPS SUPPLY CHAIN SOL… | United States | $102K | $34K | Mid |
| 8 | ALISSA HEALTHCARE RE… | United Kingdom | $100K | $100K | Premium |
| 9 | LIFESTAR PHARMA LLC | United States | $99K | $12K | Budget |
| 10 | EVERSANA LIFESCIENCE… | United States | $94K | $47K | Premium |
| 11 | UPS HEALTHCARE LOGIS… | United States | $94K | $47K | Premium |
| 12 | J.KNIPPER & COMPANY | United States | $86K | $43K | Premium |
| 13 | ARROW PHARMACEUTICAL… | Australia | $74K | $25K | Mid |
| 14 | DR REDDYS LABORATORI… | United States | $64K | $32K | Mid |
| 15 | ASCEND LABORATORIES … | United States | $61K | $30K | Mid |
| 16 | AMNEAL PHARMACEUTICA… | United States | $55K | $18K | Mid |
| 17 | WORLD HEALTH ORGANIZ… | Israel | $54K | $54K | Premium |
| 18 | NOVADOZ PHARMACEUTIC… | United States | $54K | $11K | Budget |
| 19 | CAMBER PHARMACEUTICA… | United States | $44K | $15K | Budget |
| 20 | TIME-CAP LABS INC | United States | $40K | $6K | Budget |
| 21 | GALINOS FARM DOO ILI… | North Macedonia | $32K | $8K | Budget |
| 22 | BLESSINGS INTERNATIO… | United States | $28K | $14K | Budget |
| 23 | PLANET PHARMA SA | France | $23K | $23K | Mid |
| 24 | SEVEN PHARMA CHILE SPA | Chile | $22K | $22K | Mid |
| 25 | GRANULES USA | United States | $18K | $18K | Mid |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 ALEMBIC PHARMACEUTICALS LTD → J. KNIPPER & COMPANY is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian famotidine prices vary by supplier, country and dosage form
KEY TAKEAWAY
Famotidine prices span 2112081× ($0.0010 → $2108.48). The coefficient of variation is 8.13. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0010 | Lowest observed unit price |
| P5 | $0.0078 | 5th percentile |
| P25 | $0.065 | 25th percentile (Q1) |
| Median | $0.137 | 50th percentile (Q2) |
| P75 | $2.88 | 75th percentile (Q3) |
| P95 | $11.12 | 95th percentile |
| Max | $2.1K | Highest observed unit price |
| Mean | $29.02 | Arithmetic average |
| CV | 813% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 MEDREICH LTD prices at $2K/unit vs market median $0.137.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. ALEMBIC PHARMACEUTICALS LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. MYLAN LABORATORIES LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. UNISON PHARMACEUTICALS PVT Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. THRIVE THERAPEUTIC PVT Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Oct 2025 | MAIVA PHARMA PVT… | United States | Injection | 3 | $47K | $14K | Sterile formulation premium |
| Oct 2025 | MAIVA PHARMA PVT… | United States | Injection | 3 | $47K | $14K | Sterile formulation premium |
| Oct 2025 | MEDREICH LTD | Japan | Tablet | 49 | $104K | $2K | Specialty / small-batch |
| Nov 2025 | MEDREICH LTD | Japan | Tablet | 39 | $82K | $2K | Specialty / small-batch |
| Nov 2025 | MEDREICH LTD | Japan | Tablet | 10 | $21K | $2K | Specialty / small-batch |
| Dec 2025 | ANNORA PHARMA PV… | United States | Tablet | 459 | $40K | $87.62 | Specialty / small-batch |
| Nov 2025 | MYLAN LABORATORI… | United States | Injection | 2K | $34K | $17.88 | Sterile formulation premium |
| Nov 2025 | MEDOPHARM PVT LTD | United States | Tablet | 990 | $14K | $14.17 | Specialty / small-batch |
| Nov 2025 | MEDOPHARM PVT LTD | United States | Tablet | 990 | $14K | $14.17 | Specialty / small-batch |
| Nov 2025 | MEDOPHARM PVT LTD | United States | Tablet | 990 | $14K | $14.17 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | DERRIC WOOD | United Arab Emirates | Tablet | 10 | $0.012 | $0.0012 | Bulk generic tablet |
| Dec 2025 | D VIJAY PHARMA P… | Seychelles | Tablet | 202K | $882.10 | $0.0044 | Bulk generic tablet |
| Dec 2025 | D VIJAY PHARMA P… | Seychelles | Tablet | 98K | $430.57 | $0.0044 | Bulk generic tablet |
| Oct 2025 | ANNORA PHARMA PV… | United States | Tablet | 2.2M | $11K | $0.0052 | Bulk generic tablet |
| Oct 2025 | ANNORA PHARMA PV… | United States | Tablet | 2.2M | $11K | $0.0052 | Bulk generic tablet |
| Oct 2025 | DRREDDYS LABORAT… | United States | Tablet | 4.3M | $28K | $0.0065 | Bulk generic tablet |
| Oct 2025 | VKT PHARMA PVT LTD | United States | Tablet | 2.7M | $18K | $0.0066 | Bulk generic tablet |
| Dec 2025 | DRREDDYS LABORAT… | United States | Tablet | 5.4M | $36K | $0.0067 | Bulk generic tablet |
| Dec 2025 | ANNORA PHARMA PV… | United States | Tablet | 1.7M | $11K | $0.0068 | Bulk generic tablet |
| Oct 2025 | ANNORA PHARMA PV… | United States | Tablet | 636K | $4K | $0.0068 | Bulk generic tablet |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship famotidine, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Famotidine leaves India through 19+ ports. The top 5 (MUNDRA SEA, NHAVA SHEVA SEA (JNPT), HYDERABAD ICD) handle 83.3% of total USD. SEA moves 28% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 MUNDRA SEA handles $1.1M — top 19 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 Norfolk is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
SEA dominates at 28% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$2.2M
51.2% of USD · 28.0% of ships
ICD
$1.3M
29.3% of USD · 22.4% of ships
AIR
$855K
19.5% of USD · 49.6% of ships
Fig 8.3 The dominant corridor is MUNDRA SEA → Sea → N. America ($920K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
United Arab Emirates is the most concentrated destination (HHI 10000, 1 suppliers). Belgium is the most competitive (HHI 0).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 United Arab Emirates (HHI 10,000) is the most concentrated — United States (HHI 1,893) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 18 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| J. KNIPPER & COMPANY | United States | ALEMBIC PHARMACE… | $987K | 22 | CRITICAL |
| MYLAN INSTITUTIONAL … | United States | MYLAN LABORATORI… | $578K | 17 | CRITICAL |
| MEIJI SEIKA PHARMATE… | Japan | MEDREICH LTD | $207K | 3 | HIGH |
| SEVEN PHARMA LTDA | Costa Rica | WALLACE PHARMACE… | $188K | 2 | HIGH |
| REED-LANE INC | United States | DRREDDYS LABORAT… | $147K | 2 | HIGH |
| EVERSANA LIFE SCIENC… | United States | MAIVA PHARMA PVT… | $104K | 2 | HIGH |
| UPS SUPPLY CHAIN SOL… | United States | LUPIN LTD | $102K | 3 | HIGH |
| ALISSA HEALTHCARE RE… | United Kingdom | UNISON PHARMACEU… | $100K | 1 | HIGH |
Conclusion: 49 buyers depend on exactly one Indian supplier, representing $3.4M in trade. 2 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| United States | Tier 2 (competitive) | 3–5 days (air) | $1–$10/unit | MEDIUM | Price + relationship |
| Turkmenistan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Japan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Costa Rica | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Israel | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| United Kingdom | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Australia | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Nigeria | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| France | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Chile | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Slovakia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Afghanistan | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Greece | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| North Macedonia | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Sri Lanka | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 1 markets in the Growth Opportunity zone (competitive + growing). 12 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: United States are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in United States | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit United Arab Emirates lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Turkmenistan (3 suppliers) | This Q | HIGH |
| A6 | Enter Japan (1 suppliers) | This Q | MED |
| A8 | Build Turkmenistan distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for United States tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Turkmenistan | Asia | 3 | $219K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 2 | Japan | Asia | 1 | $207K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Costa Rica | Other | 1 | $188K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Israel | Other | 1 | $108K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | United Kingdom | Other | 1 | $100K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Australia | Other | 1 | $74K | -21.4% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Nigeria | Africa | 1 | $24K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | France | Other | 1 | $23K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Chile | Other | 1 | $22K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Slovakia | Other | 1 | $21K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Afghanistan | Asia | 4 | $18K | -94.3% | LOW | Low competition (4 suppliers), accessible market |
| 12 | Greece | Other | 1 | $16K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | North Macedonia | Other | 1 | $16K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Sri Lanka | Asia | 2 | $14K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Lebanon | Other | 1 | $13K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 246 2025-Q4 Famotidine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/famotidine
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 246 2025-Q4 famotidine shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian famotidine shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
246
across all regions
TOTAL USD
$4.37M
2025-Q4 FOB value
UNITS
143.3M
tablets, capsules, etc.
SUPPLIERS
49
Indian exporters
BUYERS
51
global importers
COUNTRIES
28
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $38K (0.9%), spanning 5 countries.
49 Indian suppliers shipped to 51 buyers across 28 countries — average shipment value $18K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
5 countries · 24 shipments · $38K · 10 Indian suppliers · 9 buyers
SHIPMENTS
24
USD
$38K
COUNTRIES
5
SUPPLIERS
10
BUYERS
9
HHI
4,621
concentrated
Top 5 destination countries in Africa
1
Nigeria (62.0%)
$24K
2
Cameroon (27.1%)
$10K
3
DR Congo (5.3%)
$2K
4
Seychelles (4.7%)
$2K
5
Mauritius (0.8%)
$323.19
Top 10 Indian suppliers into Africa
1
RATNATRIS PHARMACEUTICALS PVT LTD
$24K
2
SHALINA LABORATORIES PVT LTD
$10K
3
PHARMAX INDIA PVT LTD
$2K
4
D VIJAY PHARMA PVT LTD
$1K
5
SAVA HEALTHCARE LTD
$218.25
6
CHOUDHARI IMPEX
$212.55
7
HLL LIFECARE LTD
$199.66
8
3S PHARMACEUTICALS INDIA PVT LTD
$104.94
9
CHEMSELECT PVT LTD
$51.61
10
MEDMALL PHARMACY PVT LTD
$8.27
Top 8 Africa importers
1
MEDAF PHARMACY SURLCENTRAL AFRICAN · Cameroon
$10K
2
UNIQUE PHARMA · DR Congo
$2K
3
HEALTHCARE CARE AGENCY · Seychelles
$1K
4
REGENCY EXIM TRADE LTD · Mauritius
$218.25
5
MINISTRY OF HEALTH · Seychelles
$199.66
6
FOR THE ORDER OF · Mauritius
$104.94
7
CAREWELL PHARMACY (PTY)LTD · Seychelles
$51.61
8
PRISM INTERNATIONAL LLC · Seychelles
$8.27
Top 3 dosage forms
1
Injection
$26K
2
Tablet
$12K
3
Gel
$220.69
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 7 | $11K | $2K |
| Nov | 4 | $362.04 | $90.51 |
| Dec | 13 | $27K | $2K |
Shipment register · 24 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — RATNATRIS PHARMACEUTICALS PVT LTD · 1 shipments · $24K | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Nigeria | Injection | 10.8K | NOS | $2.19 | $24K | AHMEDABAD ICD | APAPA | ICD |
| SUPPLIER #2 — SHALINA LABORATORIES PVT LTD · 1 shipments · $10K | |||||||||||
| 2 | Oct 2025 | MEDAF PHARMACY SURLCENTRAL AFRICAN | Cameroon | Tablet | 30.0K | NOS | $0.344 | $10K | NHAVA SHEVA SEA (JNPT) | Bangui | SEA |
| SUPPLIER #3 — PHARMAX INDIA PVT LTD · 1 shipments · $2K | |||||||||||
| 3 | Dec 2025 | UNIQUE PHARMA | DR Congo | Injection | 12.5K | NOS | $0.163 | $2K | NHAVA SHEVA SEA (JNPT) | Matadi | SEA |
| SUPPLIER #4 — D VIJAY PHARMA PVT LTD · 2 shipments · $1K | |||||||||||
| 4 | Dec 2025 | HEALTHCARE CARE AGENCY | Seychelles | Tablet | 98.4K | NOS | $0.0044 | $430.57 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR |
| 5 | Dec 2025 | HEALTHCARE CARE AGENCY | Seychelles | Tablet | 201.6K | NOS | $0.0044 | $882.10 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR |
| SUPPLIER #5 — SAVA HEALTHCARE LTD · 10 shipments · $218.25 | |||||||||||
| 6 | Nov 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 24 | NOS | $3.19 | $76.57 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 7 | Nov 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 6 | NOS | $5.70 | $34.20 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 8 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 3 | NOS | $3.24 | $9.72 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 9 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 9 | NOS | $3.24 | $29.17 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 10 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 3 | NOS | $3.24 | $9.72 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 11 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 1 | NOS | $5.78 | $5.78 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 12 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 8 | NOS | $5.78 | $46.21 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 13 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 1 | NOS | $6.28 | $6.28 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 14 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 3 | NOS | $0.070 | $0.210 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 15 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 11 | NOS | $0.036 | $0.398 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| SUPPLIER #6 — CHOUDHARI IMPEX · 4 shipments · $212.55 | |||||||||||
| 16 | Oct 2025 | UNLISTED BUYER | Seychelles | Gel | 60 | NOS | $2.82 | $169.08 | CHENNAI AIR | MAHE ISLAND | AIR |
| 17 | Oct 2025 | UNLISTED BUYER | Seychelles | Tablet | 200 | NOS | $0.201 | $40.26 | CHENNAI AIR | MAHE ISLAND | AIR |
| 18 | Oct 2025 | UNLISTED BUYER | Seychelles | Tablet | 20 | NOS | $0.081 | $1.61 | CHENNAI AIR | MAHE ISLAND | AIR |
| 19 | Oct 2025 | UNLISTED BUYER | Seychelles | Tablet | 20 | NOS | $0.080 | $1.60 | CHENNAI AIR | MAHE ISLAND | AIR |
| SUPPLIER #7 — HLL LIFECARE LTD · 1 shipments · $199.66 | |||||||||||
| 20 | Nov 2025 | MINISTRY OF HEALTH | Seychelles | Tablet | 200.0K | NOS | $0.0010 | $199.66 | DELHI AIR | MAHE ISLAND | AIR |
| SUPPLIER #8 — 3S PHARMACEUTICALS INDIA PVT LTD · 1 shipments · $104.94 | |||||||||||
| 21 | Dec 2025 | FOR THE ORDER OF | Mauritius | Tablet | 14 | NOS | $7.50 | $104.94 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| SUPPLIER #9 — CHEMSELECT PVT LTD · 1 shipments · $51.61 | |||||||||||
| 22 | Nov 2025 | CAREWELL PHARMACY (PTY)LTD | Seychelles | Gel | 33 | NOS | $1.56 | $51.61 | COCHIN AIR | MAHE ISLAND | AIR |
| SUPPLIER #10 — MEDMALL PHARMACY PVT LTD · 2 shipments · $8.27 | |||||||||||
| 23 | Oct 2025 | PRISM INTERNATIONAL LLC | Seychelles | Tablet | 60 | NOS | $0.049 | $2.92 | HYDERABAD AIR | MAHE ISLAND | AIR |
| 24 | Oct 2025 | PRISM INTERNATIONAL LLC | Seychelles | Tablet | 60 | NOS | $0.089 | $5.35 | HYDERABAD AIR | MAHE ISLAND | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
11 countries · 85 shipments · $591K · 15 Indian suppliers · 17 buyers
SHIPMENTS
85
USD
$591K
COUNTRIES
11
SUPPLIERS
15
BUYERS
17
HHI
2,988
concentrated
Top 11 destination countries in Asia
1
Turkmenistan (37.1%)
$219K
2
Japan (35.1%)
$207K
3
Israel (18.2%)
$108K
4
Afghanistan (3.0%)
$18K
5
Sri Lanka (2.4%)
$14K
6
Lebanon (2.2%)
$13K
7
Turkey (1.8%)
$11K
8
Myanmar (0.2%)
$1K
9
Singapore (0.1%)
$300.35
10
Maldives (0.0%)
$128.29
11
United Arab Emirates (0.0%)
$66.03
Top 15 Indian suppliers into Asia
1
THRIVE THERAPEUTIC PVT LTD
$214K
2
MEDREICH LTD
$207K
3
MEDOPHARM
$124K
4
LABORATE PHARMACEUTICALS INDIA LTD
$13K
5
PROTECH BIO SYSTEMS PVT LTD
$11K
6
ASHISH MEDICAMENTS LLP
$7K
7
PROTECH TELELINKS
$5K
8
ARBRO PHARMACEUTICALS PVT LTD
$4K
9
NOVATRA PHARMA PLC
$3K
10
SUN PHARMACEUTICAL INDUSTRIES LTD
$1K
11
CIAN HEALTHCARE LTD
$323.49
12
SANITAS MEDTECH INSTITUTE PVT LTD
$300.35
13
CURETON BIOTECH PVT LTD
$271.71
14
GET EXPORTS & IMPORTS SHOP
$128.29
15
DERRIC WOOD
$66.03
Top 15 Asia importers
1
MEIJI SEIKA PHARMATECH CO LTD · Japan
$207K
2
WORLD HEALTH ORGANIZATION · Israel
$54K
3
U.N.R.W.A · Lebanon
$13K
4
NAHEB HAMZA LTD · Afghanistan
$11K
5
PHARMA ASSOCIATES · Sri Lanka
$11K
6
SAGLYK E.S · Turkmenistan
$5K
7
IMOCO EXPRESS SERVICE ULUSL NAKL · Turkey
$4K
8
ALARIS LANKA (PVT) LTD · Sri Lanka
$3K
9
RAHMAN WALI LTD · Afghanistan
$2K
10
MUSBAH TASNIM TRADING LTD · Afghanistan
$2K
11
MAIN PHARMACY ASSOCIATION, MINISTRY · Turkmenistan
$323.49
12
SUCCESS INTER LINK PTE LTD · Singapore
$300.35
13
MUKBARAK HASHIMI LTD · Afghanistan
$271.71
14
MAZI CHEMIST · Maldives
$128.29
15
EMIRATES POST COMPANY · United Arab Emirates
$57.82
Top 4 dosage forms
1
Tablet
$582K
2
Injection
$5K
3
Unknown
$4K
4
Gel
$128.29
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 5 | $125K | $25K |
| Nov | 61 | $249K | $4K |
| Dec | 19 | $217K | $11K |
Shipment register · 85 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — THRIVE THERAPEUTIC PVT LTD · 2 shipments · $214K | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Turkmenistan | Tablet | 35.0K | NOS | $3.05 | $107K | DELHI AIR | AIR | |
| 2 | Dec 2025 | UNLISTED BUYER | Turkmenistan | Tablet | 35.0K | NOS | $3.05 | $107K | DELHI AIR | ASHKHABAD | AIR |
| SUPPLIER #2 — MEDREICH LTD · 3 shipments · $207K | |||||||||||
| 3 | Oct 2025 | MEIJI SEIKA PHARMATECH CO LTD | Japan | Tablet | 49 | KGS | $2K | $104K | BANGALORE AIR | TOKYO - NARITA | AIR |
| 4 | Nov 2025 | MEIJI SEIKA PHARMATECH CO LTD | Japan | Tablet | 39 | KGS | $2K | $82K | BANGALORE AIR | TOKYO - NARITA | AIR |
| 5 | Nov 2025 | MEIJI SEIKA PHARMATECH CO LTD | Japan | Tablet | 10 | KGS | $2K | $21K | BANGALORE AIR | TOKYO - NARITA | AIR |
| SUPPLIER #3 — MEDOPHARM · 4 shipments · $124K | |||||||||||
| 6 | Oct 2025 | U.N.R.W.A | Lebanon | Tablet | 1.7K | NOS | $7.58 | $13K | ENNORE SEA | Beirut | SEA |
| 7 | Nov 2025 | WORLD HEALTH ORGANIZATION | Israel | Tablet | 69.0K | NOS | $0.779 | $54K | KATTUPALLI PORT SEA | Ashdod | SEA |
| 8 | Nov 2025 | UNKNOWN BUYER | Israel | Tablet | 69.0K | NOS | $0.779 | $54K | KATTUPALLI PORT SEA | Ashdod | SEA |
| 9 | Dec 2025 | ALARIS LANKA (PVT) LTD | Sri Lanka | Tablet | 4.8K | NOS | $0.657 | $3K | CHENNAI SEA | Colombo | SEA |
| SUPPLIER #4 — LABORATE PHARMACEUTICALS INDIA LTD · 2 shipments · $13K | |||||||||||
| 10 | Oct 2025 | UNLISTED BUYER | Afghanistan | Tablet | 10.0K | NOS | $0.248 | $2K | PATLI ICD | Kabul | ICD |
| 11 | Nov 2025 | PHARMA ASSOCIATES | Sri Lanka | Tablet | 24.7K | NOS | $0.438 | $11K | PATLI ICD | Colombo | ICD |
| SUPPLIER #5 — PROTECH BIO SYSTEMS PVT LTD · 2 shipments · $11K | |||||||||||
| 12 | Nov 2025 | NAHEB HAMZA LTD | Afghanistan | Tablet | 10.0K | NOS | $0.554 | $6K | TUGHLAKABAD ICD | Kabul | ICD |
| 13 | Nov 2025 | NAHEB HAMZA LTD | Afghanistan | Tablet | 10.1K | NOS | $0.554 | $6K | TUGHLAKABAD ICD | Kabul | ICD |
| SUPPLIER #6 — ASHISH MEDICAMENTS LLP · 2 shipments · $7K | |||||||||||
| 14 | Nov 2025 | IMOCO EXPRESS SERVICE ULUSL NAKL | Turkey | 6.9K | NOS | $0.510 | $4K | TUGHLAKABAD ICD | Mersin | ICD | |
| 15 | Nov 2025 | UNKNOWN BUYER | Turkey | Tablet | 6.9K | NOS | $0.510 | $4K | TUGHLAKABAD ICD | Mersin | ICD |
| SUPPLIER #7 — PROTECH TELELINKS · 1 shipments · $5K | |||||||||||
| 16 | Nov 2025 | SAGLYK E.S | Turkmenistan | Injection | 3.4K | NOS | $1.48 | $5K | NHAVA SHEVA SEA (JNPT) | Ashkhabad | SEA |
| SUPPLIER #8 — ARBRO PHARMACEUTICALS PVT LTD · 2 shipments · $4K | |||||||||||
| 17 | Oct 2025 | RAHMAN WALI LTD | Afghanistan | Tablet | 11.0K | NOS | $0.210 | $2K | PATLI ICD | KANDAHAR | ICD |
| 18 | Nov 2025 | MUSBAH TASNIM TRADING LTD | Afghanistan | Tablet | 8.7K | NOS | $0.194 | $2K | PATLI ICD | Kandahar | ICD |
| SUPPLIER #9 — NOVATRA PHARMA PLC · 1 shipments · $3K | |||||||||||
| 19 | Oct 2025 | UNLISTED BUYER | Turkey | Tablet | 20.0K | NOS | $0.174 | $3K | NHAVA SHEVA SEA (JNPT) | Erbil International | SEA |
| SUPPLIER #10 — SUN PHARMACEUTICAL INDUSTRIES LTD · 1 shipments · $1K | |||||||||||
| 20 | Nov 2025 | UNKNOWN BUYER | Myanmar | Tablet | 322 | PCS | $3.44 | $1K | CHENNAI SEA | Yangon | SEA |
| SUPPLIER #11 — CIAN HEALTHCARE LTD · 2 shipments · $323.49 | |||||||||||
| 21 | Dec 2025 | MAIN PHARMACY ASSOCIATION, MINISTRY | Turkmenistan | Tablet | 4.9K | NOS | $0.033 | $161.83 | DELHI AIR | ASHKHABAD | AIR |
| 22 | Dec 2025 | MAIN PHARMACY ASSOCIATION, MINISTRY | Turkmenistan | Tablet | 4.9K | NOS | $0.033 | $161.66 | DELHI AIR | ASHKHABAD | AIR |
| SUPPLIER #12 — SANITAS MEDTECH INSTITUTE PVT LTD · 1 shipments · $300.35 | |||||||||||
| 23 | Nov 2025 | SUCCESS INTER LINK PTE LTD | Singapore | Tablet | 50 | NOS | $6.01 | $300.35 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #13 — CURETON BIOTECH PVT LTD · 2 shipments · $271.71 | |||||||||||
| 24 | Dec 2025 | MUKBARAK HASHIMI LTD | Afghanistan | Tablet | 2.9K | NOS | $0.051 | $146.87 | TUGHLAKABAD ICD | Kandahar | ICD |
| 25 | Dec 2025 | MUKBARAK HASHIMI LTD | Afghanistan | Tablet | 2.0K | NOS | $0.061 | $124.84 | TUGHLAKABAD ICD | Kandahar | ICD |
| SUPPLIER #14 — GET EXPORTS & IMPORTS SHOP · 1 shipments · $128.29 | |||||||||||
| 26 | Nov 2025 | MAZI CHEMIST | Maldives | Gel | 50 | NOS | $2.57 | $128.29 | CHENNAI AIR | MALE | AIR |
| SUPPLIER #15 — DERRIC WOOD · 59 shipments · $66.03 | |||||||||||
| 27 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.141 | $1.69 | DELHI AIR | DUBAI | AIR |
| 28 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.067 | $0.402 | DELHI AIR | DUBAI | AIR |
| 29 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 24 | PCS | $0.133 | $3.20 | DELHI AIR | DUBAI | AIR |
| 30 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.133 | $0.800 | DELHI AIR | DUBAI | AIR |
| 31 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $0.067 | $1.20 | DELHI AIR | DUBAI | AIR |
| 32 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $0.134 | $2.41 | DELHI AIR | DUBAI | AIR |
| 33 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $0.067 | $1.20 | DELHI AIR | DUBAI | AIR |
| 34 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $0.134 | $2.41 | DELHI AIR | DUBAI | AIR |
| 35 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.067 | $0.402 | DELHI AIR | DUBAI | AIR |
| 36 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 24 | PCS | $0.133 | $3.20 | DELHI AIR | DUBAI | AIR |
| 37 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.133 | $0.800 | DELHI AIR | DUBAI | AIR |
| 38 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 26 | PCS | $0.067 | $1.74 | DELHI AIR | DUBAI | AIR |
| 39 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $0.122 | $0.245 | DELHI AIR | DUBAI | AIR |
| 40 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 26 | PCS | $0.067 | $1.74 | DELHI AIR | DUBAI | AIR |
| 41 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 2 | PCS | $0.122 | $0.245 | DELHI AIR | DUBAI | AIR |
| 42 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 26 | PCS | $0.067 | $1.74 | DELHI AIR | DUBAI | AIR |
| 43 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $0.122 | $0.245 | DELHI AIR | DUBAI | AIR |
| 44 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.067 | $0.399 | DELHI AIR | DUBAI | AIR |
| 45 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.067 | $0.399 | DELHI AIR | DUBAI | AIR |
| 46 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.122 | $1.46 | DELHI AIR | DUBAI | AIR |
| 47 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 26 | PCS | $0.067 | $1.74 | DELHI AIR | DUBAI | AIR |
| 48 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 2 | PCS | $0.122 | $0.245 | DELHI AIR | DUBAI | AIR |
| 49 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 6 | PCS | $0.067 | $0.399 | DELHI AIR | DUBAI | AIR |
| 50 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 6 | PCS | $0.067 | $0.399 | DELHI AIR | DUBAI | AIR |
| 51 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 12 | PCS | $0.122 | $1.46 | DELHI AIR | DUBAI | AIR |
| 52 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 26 | PCS | $0.067 | $1.74 | DELHI AIR | DUBAI | AIR |
| 53 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $0.122 | $0.245 | DELHI AIR | DUBAI | AIR |
| 54 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 26 | PCS | $0.067 | $1.74 | DELHI AIR | DUBAI | AIR |
| 55 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $0.122 | $0.245 | DELHI AIR | DUBAI | AIR |
| 56 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 26 | PCS | $0.067 | $1.74 | DELHI AIR | DUBAI | AIR |
| 57 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 2 | PCS | $0.122 | $0.245 | DELHI AIR | DUBAI | AIR |
| 58 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 8 | PCS | $0.067 | $0.535 | DELHI AIR | DUBAI | AIR |
| 59 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $0.123 | $2.21 | DELHI AIR | DUBAI | AIR |
| 60 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.067 | $0.800 | DELHI AIR | DUBAI | AIR |
| 61 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.067 | $0.805 | DELHI AIR | DUBAI | AIR |
| 62 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.122 | $1.47 | DELHI AIR | DUBAI | AIR |
| 63 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.122 | $1.47 | DELHI AIR | DUBAI | AIR |
| 64 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 30 | PCS | $0.067 | $2.01 | DELHI AIR | DUBAI | AIR |
| 65 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.123 | $1.47 | DELHI AIR | DUBAI | AIR |
| 66 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 30 | PCS | $0.067 | $2.02 | DELHI AIR | DUBAI | AIR |
| 67 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.124 | $1.48 | DELHI AIR | DUBAI | AIR |
| 68 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.067 | $0.809 | DELHI AIR | DUBAI | AIR |
| 69 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.123 | $1.48 | DELHI AIR | DUBAI | AIR |
| 70 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.067 | $0.405 | DELHI AIR | DUBAI | AIR |
| 71 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.067 | $0.405 | DELHI AIR | DUBAI | AIR |
| 72 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 24 | PCS | $0.067 | $1.62 | DELHI AIR | DUBAI | AIR |
| 73 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.123 | $1.48 | DELHI AIR | DUBAI | AIR |
| 74 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 4 | PCS | $0.123 | $0.492 | DELHI AIR | DUBAI | AIR |
| 75 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 4 | PCS | $0.126 | $0.506 | DELHI AIR | DUBAI | AIR |
| 76 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.069 | $0.831 | DELHI AIR | DUBAI | AIR |
| 77 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.0000 | $0.0000 | DELHI AIR | DUBAI | AIR |
| 78 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.0007 | $0.0040 | DELHI AIR | DUBAI | AIR |
| 79 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.0007 | $0.0080 | DELHI AIR | DUBAI | AIR |
| 80 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 10 | PCS | $0.0012 | $0.012 | DELHI AIR | DUBAI | AIR |
| 81 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $0.070 | $1.25 | DELHI AIR | DUBAI | AIR |
| 82 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.128 | $1.53 | DELHI AIR | DUBAI | AIR |
| 83 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.069 | $0.416 | DELHI AIR | DUBAI | AIR |
| 84 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.070 | $0.834 | DELHI AIR | DUBAI | AIR |
| 85 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 28 | PCS | $0.127 | $3.57 | DELHI AIR | DUBAI | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
6 countries · 12 shipments · $176K · 5 Indian suppliers · 5 buyers
SHIPMENTS
12
USD
$176K
COUNTRIES
6
SUPPLIERS
5
BUYERS
5
HHI
3,867
concentrated
Top 6 destination countries in Europe
1
United Kingdom (56.8%)
$100K
2
France (13.2%)
$23K
3
Slovakia (11.9%)
$21K
4
Greece (9.2%)
$16K
5
North Macedonia (8.9%)
$16K
6
Belgium · Belgium
$0.0000
Top 5 Indian suppliers into Europe
1
UNISON PHARMACEUTICALS PVT LTD
$100K
2
OCEAN PHARMACEUTICAL
$32K
3
AJANTA PHARMA LTD
$23K
4
VINDHYA INTERNATIONAL
$21K
5
MILAN LABORATORIES (INDIA) PVT LTD
$0.0000
Top 3 Europe importers
1
ALISSA HEALTHCARE RESEARCH LTD · United Kingdom
$100K
2
GALINOS FARM DOO ILINDEN · North Macedonia
$32K
3
PLANET PHARMA SA · France
$23K
Top 3 dosage forms
1
Tablet
$123K
2
Injection
$53K
3
Unknown
$0.0000
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $5K | $5K |
| Nov | 7 | $139K | $20K |
| Dec | 4 | $32K | $8K |
Shipment register · 12 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — UNISON PHARMACEUTICALS PVT LTD · 1 shipments · $100K | |||||||||||
| 1 | Nov 2025 | ALISSA HEALTHCARE RESEARCH LTD | United Kingdom | Tablet | 167.1K | NOS | $0.599 | $100K | MUNDRA SEA | Southampton | SEA |
| SUPPLIER #2 — OCEAN PHARMACEUTICAL · 4 shipments · $32K | |||||||||||
| 2 | Dec 2025 | GALINOS FARM DOO ILINDEN | North Macedonia | Injection | 10.0K | NOS | $0.785 | $8K | MUMBAI AIR (SAHAR) | SKOPJE | AIR |
| 3 | Dec 2025 | GALINOS FARM DOO ILINDEN | North Macedonia | Injection | 10.0K | NOS | $0.785 | $8K | AHMEDABAD AIR | SKOPJE | AIR |
| 4 | Dec 2025 | GALINOS FARM DOO ILINDEN | Greece | Injection | 5.0K | NOS | $0.816 | $4K | AHMEDABAD ICD | THESSALONIKI | ICD |
| 5 | Dec 2025 | GALINOS FARM DOO ILINDEN | Greece | Injection | 15.0K | NOS | $0.816 | $12K | AHMEDABAD ICD | THESSALONIKI | ICD |
| SUPPLIER #3 — AJANTA PHARMA LTD · 1 shipments · $23K | |||||||||||
| 6 | Nov 2025 | PLANET PHARMA SA | France | Tablet | 8.8K | NOS | $2.65 | $23K | NHAVA SHEVA SEA (JNPT) | Le Havre | SEA |
| SUPPLIER #4 — VINDHYA INTERNATIONAL · 3 shipments · $21K | |||||||||||
| 7 | Oct 2025 | UNLISTED BUYER | Slovakia | Injection | 1.0K | NOS | $4.96 | $5K | AHMEDABAD AIR | BRAZZAVILLE | AIR |
| 8 | Nov 2025 | UNLISTED BUYER | Slovakia | Injection | 1.5K | NOS | $5.22 | $8K | AHMEDABAD AIR | BRAZZAVILLE | AIR |
| 9 | Nov 2025 | UNKNOWN BUYER | Slovakia | Injection | 1.5K | NOS | $5.22 | $8K | AHMEDABAD AIR | BRAZZAVILLE | AIR |
| SUPPLIER #5 — MILAN LABORATORIES (INDIA) PVT LTD · 3 shipments · $0.0000 | |||||||||||
| 10 | Nov 2025 | UNLISTED BUYER | Belgium | 0 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Antwerpen | SEA | |
| 11 | Nov 2025 | UNLISTED BUYER | Belgium | 0 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Antwerpen | SEA | |
| 12 | Nov 2025 | UNLISTED BUYER | Belgium | 0 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Antwerpen | SEA | |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
5 countries · 122 shipments · $3.50M · 18 Indian suppliers · 24 buyers
SHIPMENTS
122
USD
$3.50M
COUNTRIES
5
SUPPLIERS
18
BUYERS
24
HHI
1,705
moderate
Top 5 destination countries in Americas
1
United States (93.7%)
$3.28M
2
Costa Rica (5.4%)
$188K
3
Chile (0.6%)
$22K
4
Canada (0.3%)
$10K
5
Dominica (0.0%)
$2.02
Top 18 Indian suppliers into Americas
1
ALEMBIC PHARMACEUTICALS LTD
$1.18M
2
MYLAN LABORATORIES LTD
$578K
3
ANNORA PHARMA PVT LTD
$409K
4
DRREDDYS LABORATORIES LTD
$211K
5
MAIVA PHARMA PVT LTD
$199K
6
WALLACE PHARMACEUTICALS PVT LTD
$188K
7
LUPIN LTD
$102K
8
MANKIND PHARMA LTD
$99K
9
MICRO LABS LTD
$94K
10
ALKEM LABORATORIES LTD
$91K
11
VKT PHARMA PVT LTD
$90K
12
MSN LABORATORIES PVT LTD
$83K
13
MEDOPHARM PVT LTD
$56K
14
AMNEAL PHARMACEUTICALS PVT LTD
$55K
15
MARKSANS PHARMA LTD
$46K
16
WINDLAS BIOTECH LTD
$10K
17
VL TRADELINK PVT LTD
$26.52
18
VEA IMPEX (I) PVT LTD
$2.02
Top 22 Americas importers
1
J. KNIPPER & COMPANY · United States
$987K
2
MYLAN INSTITUTIONAL INC · United States
$578K
3
SEVEN PHARMA LTDA · Costa Rica
$188K
4
REED-LANE INC · United States
$147K
5
EVERSANA LIFE SCIENCE SERVICES LLC · United States
$104K
6
UPS SUPPLY CHAIN SOLUTIONS INC · United States
$102K
7
LIFESTAR PHARMA LLC · United States
$99K
8
EVERSANA LIFESCIENCE SERVICES · United States
$94K
9
UPS HEALTHCARE LOGISTICS & · United States
$94K
10
J.KNIPPER & COMPANY · United States
$86K
11
DR REDDYS LABORATORIES INC · United States
$64K
12
ASCEND LABORATORIES LLC · United States
$61K
13
AMNEAL PHARMACEUTICALS LLC · United States
$55K
14
NOVADOZ PHARMACEUTICALS LLC · United States
$54K
15
CAMBER PHARMACEUTICALS INC · United States
$44K
16
TIME-CAP LABS INC · United States
$40K
17
BLESSINGS INTERNATIONAL · United States
$28K
18
SEVEN PHARMA CHILE SPA · Chile
$22K
19
GRANULES USA · United States
$18K
20
JAMP PHARMA CORP · Canada
$10K
21
CAMBER CONSUMER CARE INC · United States
$9K
22
KAN ONYEMA · United States
$26.52
Top 4 dosage forms
1
Tablet
$2.21M
2
Injection
$777K
3
Suspension
$400K
4
Solution
$108K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 36 | $1.06M | $30K |
| Nov | 41 | $1.21M | $29K |
| Dec | 45 | $1.22M | $27K |
Shipment register · 122 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ALEMBIC PHARMACEUTICALS LTD · 26 shipments · $1.18M | |||||||||||
| 1 | Oct 2025 | J.KNIPPER & COMPANY | United States | Tablet | 2.7M | NOS | $0.016 | $43K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 2 | Oct 2025 | J.KNIPPER & COMPANY | United States | Tablet | 2.7M | NOS | $0.016 | $43K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 3 | Oct 2025 | J. KNIPPER & COMPANY | United States | Tablet | 5.3M | TBS | $0.0079 | $41K | MUNDRA SEA | NORFOLK | SEA |
| 4 | Oct 2025 | J. KNIPPER & COMPANY | United States | Tablet | 5.3M | NOS | $0.0079 | $42K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 5 | Oct 2025 | J. KNIPPER & COMPANY | United States | Tablet | 5.3M | NOS | $0.0079 | $42K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 6 | Oct 2025 | J. KNIPPER & COMPANY | United States | Tablet | 2.6M | TBS | $0.014 | $37K | MUNDRA SEA | NORFOLK | SEA |
| 7 | Oct 2025 | J. KNIPPER & COMPANY | United States | Tablet | 5.3M | TBS | $0.010 | $54K | MUNDRA SEA | NORFOLK | SEA |
| 8 | Oct 2025 | J. KNIPPER & COMPANY | United States | Tablet | 2.7M | TBS | $0.016 | $43K | MUNDRA SEA | NORFOLK | SEA |
| 9 | Oct 2025 | J. KNIPPER & COMPANY | United States | Tablet | 8.0M | TBS | $0.016 | $128K | MUNDRA SEA | NORFOLK | SEA |
| 10 | Oct 2025 | J. KNIPPER & COMPANY | United States | Tablet | 5.3M | TBS | $0.0078 | $41K | MUNDRA SEA | NORFOLK | SEA |
| 11 | Nov 2025 | J. KNIPPER & COMPANY | United States | Tablet | 2.6M | NOS | $0.014 | $37K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 12 | Nov 2025 | J. KNIPPER & COMPANY | United States | Tablet | 2.6M | NOS | $0.014 | $37K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 13 | Nov 2025 | J. KNIPPER & COMPANY | United States | Tablet | 5.3M | TBS | $0.011 | $56K | MUNDRA SEA | New York | SEA |
| 14 | Nov 2025 | J. KNIPPER & COMPANY | United States | Tablet | 5.3M | TBS | $0.011 | $55K | MUNDRA SEA | New York | SEA |
| 15 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 5.3M | TBS | $0.011 | $56K | MUNDRA SEA | New York | SEA |
| 16 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 5.3M | TBS | $0.011 | $55K | MUNDRA SEA | New York | SEA |
| 17 | Nov 2025 | J. KNIPPER & COMPANY | United States | Tablet | 2.7M | NOS | $0.014 | $38K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 18 | Nov 2025 | J. KNIPPER & COMPANY | United States | Tablet | 2.7M | NOS | $0.014 | $38K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 19 | Nov 2025 | J. KNIPPER & COMPANY | United States | Tablet | 5.3M | TBS | $0.010 | $55K | MUNDRA SEA | Norfolk | SEA |
| 20 | Nov 2025 | J. KNIPPER & COMPANY | United States | Tablet | 2.7M | TBS | $0.016 | $43K | MUNDRA SEA | Norfolk | SEA |
| 21 | Nov 2025 | J. KNIPPER & COMPANY | United States | Tablet | 2.7M | NOS | $0.016 | $43K | MUNDRA SEA | Norfolk | SEA |
| 22 | Dec 2025 | J. KNIPPER & COMPANY | United States | Tablet | 2.7M | NOS | $0.014 | $37K | MUNDRA SEA | Norfolk | SEA |
| 23 | Dec 2025 | J. KNIPPER & COMPANY | United States | Tablet | 2.7M | NOS | $0.014 | $38K | MUNDRA SEA | Norfolk | SEA |
| 24 | Dec 2025 | J. KNIPPER & COMPANY | United States | Tablet | 2.6M | TBS | $0.014 | $37K | MUNDRA SEA | Norfolk | SEA |
| 25 | Dec 2025 | J. KNIPPER & COMPANY | United States | Tablet | 3.8M | NOS | $0.0080 | $30K | MUNDRA SEA | Norfolk | SEA |
| 26 | Dec 2025 | J. KNIPPER & COMPANY | United States | Tablet | 972.0K | NOS | $0.014 | $14K | MUNDRA SEA | Norfolk | SEA |
| SUPPLIER #2 — MYLAN LABORATORIES LTD · 17 shipments · $578K | |||||||||||
| 27 | Nov 2025 | MYLAN INSTITUTIONAL INC | United States | Injection | 1.9K | NOS | $17.88 | $34K | BANGALORE ICD | Charleston | ICD |
| 28 | Nov 2025 | MYLAN INSTITUTIONAL INC | United States | Injection | 4.5K | NOS | $7.17 | $32K | BANGALORE ICD | Charleston | ICD |
| 29 | Nov 2025 | MYLAN INSTITUTIONAL INC | United States | Injection | 5.2K | NOS | $6.39 | $34K | BANGALORE ICD | Charleston | ICD |
| 30 | Nov 2025 | MYLAN INSTITUTIONAL INC | United States | Injection | 5.3K | NOS | $6.39 | $34K | BANGALORE ICD | Charleston | ICD |
| 31 | Nov 2025 | MYLAN INSTITUTIONAL INC | United States | Injection | 5.3K | NOS | $6.39 | $34K | BANGALORE ICD | Charleston | ICD |
| 32 | Nov 2025 | MYLAN INSTITUTIONAL INC | United States | Injection | 5.2K | NOS | $6.39 | $33K | BANGALORE ICD | Charleston | ICD |
| 33 | Dec 2025 | MYLAN INSTITUTIONAL INC | United States | Injection | 5.3K | NOS | $6.53 | $34K | BANGALORE ICD | CHARLESTON | ICD |
| 34 | Dec 2025 | MYLAN INSTITUTIONAL INC | United States | Injection | 5.3K | NOS | $6.53 | $34K | BANGALORE ICD | CHARLESTON | ICD |
| 35 | Dec 2025 | MYLAN INSTITUTIONAL INC | United States | Injection | 5.2K | NOS | $6.53 | $34K | BANGALORE ICD | CHARLESTON | ICD |
| 36 | Dec 2025 | MYLAN INSTITUTIONAL INC | United States | Injection | 5.3K | NOS | $6.53 | $34K | BANGALORE ICD | CHARLESTON | ICD |
| 37 | Dec 2025 | MYLAN INSTITUTIONAL INC | United States | Injection | 5.3K | NOS | $6.53 | $35K | BANGALORE ICD | CHARLESTON | ICD |
| 38 | Dec 2025 | MYLAN INSTITUTIONAL INC | United States | Injection | 5.3K | NOS | $6.53 | $34K | BANGALORE ICD | CHARLESTON | ICD |
| 39 | Dec 2025 | MYLAN INSTITUTIONAL INC | United States | Injection | 5.3K | NOS | $6.53 | $34K | BANGALORE ICD | CHARLESTON | ICD |
| 40 | Dec 2025 | MYLAN INSTITUTIONAL INC | United States | Injection | 5.3K | NOS | $6.53 | $34K | BANGALORE ICD | CHARLESTON | ICD |
| 41 | Dec 2025 | MYLAN INSTITUTIONAL INC | United States | Injection | 5.3K | NOS | $6.53 | $34K | BANGALORE ICD | CHARLESTON | ICD |
| 42 | Dec 2025 | MYLAN INSTITUTIONAL INC | United States | Injection | 5.3K | NOS | $6.53 | $35K | BANGALORE ICD | CHARLESTON | ICD |
| 43 | Dec 2025 | MYLAN INSTITUTIONAL INC | United States | Injection | 5.1K | NOS | $6.53 | $33K | BANGALORE ICD | CHARLESTON | ICD |
| SUPPLIER #3 — ANNORA PHARMA PVT LTD · 18 shipments · $409K | |||||||||||
| 44 | Oct 2025 | CAMBER CONSUMER CARE INC | United States | Tablet | 368.6K | NOS | $0.013 | $5K | HYDERABAD AIR | NEWARK, NJ | AIR |
| 45 | Oct 2025 | CAMBER CONSUMER CARE INC | United States | Tablet | 368.6K | NOS | $0.013 | $5K | HYDERABAD AIR | NEWARK, NJ | AIR |
| 46 | Oct 2025 | UNLISTED BUYER | United States | Solution | 23.3K | NOS | $1.26 | $29K | HYDERABAD ICD | NEW YORK | ICD |
| 47 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 1.2K | NOS | $4.02 | $5K | HYDERABAD ICD | NEW YORK | ICD |
| 48 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 21.2K | NOS | $0.684 | $15K | HYDERABAD ICD | NEW YORK | ICD |
| 49 | Oct 2025 | CAMBER PHARMACEUTICALS INC | United States | Solution | 21.5K | NOS | $1.00 | $22K | HYDERABAD AIR | NEWARK, NJ | AIR |
| 50 | Oct 2025 | UNLISTED BUYER | United States | Solution | 45.1K | NOS | $1.27 | $57K | HYDERABAD ICD | NEW YORK | ICD |
| 51 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 22.1K | NOS | $0.675 | $15K | HYDERABAD ICD | NEW YORK | ICD |
| 52 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 301.7K | NOS | $0.019 | $6K | HYDERABAD ICD | NEW YORK | ICD |
| 53 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 1.0M | NOS | $0.015 | $15K | HYDERABAD ICD | NEW YORK | ICD |
| 54 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 636.0K | NOS | $0.0068 | $4K | HYDERABAD ICD | NEW YORK | ICD |
| 55 | Oct 2025 | CAMBER PHARMACEUTICALS INC | United States | Tablet | 2.2M | NOS | $0.0052 | $11K | HYDERABAD AIR | NEWARK, NJ | AIR |
| 56 | Oct 2025 | CAMBER PHARMACEUTICALS INC | United States | Tablet | 2.2M | NOS | $0.0052 | $11K | HYDERABAD AIR | NEWARK, NJ | AIR |
| 57 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 13.2K | NOS | $5.95 | $79K | HYDERABAD ICD | NEW YORK | ICD |
| 58 | Dec 2025 | UNLISTED BUYER | United States | Suspension | 43.8K | NOS | $1.32 | $58K | HYDERABAD ICD | NEW YORK | ICD |
| 59 | Dec 2025 | SEVEN PHARMA CHILE SPA | Chile | Tablet | 2.4M | NOS | $0.0091 | $22K | HYDERABAD ICD | SAN ANTONIO | ICD |
| 60 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 1.7M | NOS | $0.0068 | $11K | HYDERABAD ICD | NEW YORK | ICD |
| 61 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 459 | NOS | $87.62 | $40K | HYDERABAD ICD | NEW YORK | ICD |
| SUPPLIER #4 — DRREDDYS LABORATORIES LTD · 4 shipments · $211K | |||||||||||
| 62 | Oct 2025 | REED-LANE INC | United States | Tablet | 2.5M | NOS | $0.020 | $50K | HYDERABAD ICD | NEWARK | ICD |
| 63 | Oct 2025 | REED-LANE INC | United States | Tablet | 7.5M | NOS | $0.013 | $97K | HYDERABAD ICD | NEWARK | ICD |
| 64 | Oct 2025 | DR REDDYS LABORATORIES INC | United States | Tablet | 4.3M | NOS | $0.0065 | $28K | HYDERABAD ICD | Charleston | ICD |
| 65 | Dec 2025 | DR REDDYS LABORATORIES INC | United States | Tablet | 5.4M | NOS | $0.0067 | $36K | HYDERABAD ICD | CHARLESTON | ICD |
| SUPPLIER #5 — MAIVA PHARMA PVT LTD · 4 shipments · $199K | |||||||||||
| 66 | Oct 2025 | EVERSANA LIFESCIENCE SERVICES | United States | Injection | 3 | KGS | $14K | $47K | NHAVA SHEVA SEA (JNPT) | Memphis | SEA |
| 67 | Oct 2025 | EVERSANA LIFESCIENCE SERVICES | United States | Injection | 3 | KGS | $14K | $47K | NHAVA SHEVA SEA (JNPT) | Memphis | SEA |
| 68 | Dec 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Injection | 84.8K | NOS | $0.612 | $52K | BANGALORE AIR | CHICAGO O'HARE INT'L | AIR |
| 69 | Dec 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Injection | 85.7K | NOS | $0.612 | $52K | BANGALORE AIR | CHICAGO O'HARE INT'L | AIR |
| SUPPLIER #6 — WALLACE PHARMACEUTICALS PVT LTD · 2 shipments · $188K | |||||||||||
| 70 | Nov 2025 | SEVEN PHARMA LTDA | Costa Rica | Tablet | 31.7K | NOS | $4.75 | $150K | NHAVA SHEVA SEA (JNPT) | Moin Bay (Puerto Lim | SEA |
| 71 | Dec 2025 | SEVEN PHARMA LTDA | Costa Rica | Tablet | 7.9K | NOS | $4.75 | $38K | NHAVA SHEVA SEA (JNPT) | Moin Bay (Puerto Lim | SEA |
| SUPPLIER #7 — LUPIN LTD · 3 shipments · $102K | |||||||||||
| 72 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Suspension | 17.3K | NOS | $1.04 | $18K | MUMBAI AIR (SAHAR) | LOUISVILLE, KY | AIR |
| 73 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Suspension | 47.8K | NOS | $1.04 | $50K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 74 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Suspension | 32.8K | NOS | $1.04 | $34K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| SUPPLIER #8 — MANKIND PHARMA LTD · 8 shipments · $99K | |||||||||||
| 75 | Nov 2025 | LIFESTAR PHARMA LLC | United States | Tablet | 1.2K | NOS | $10.80 | $13K | DELHI AIR | NEW YORK - JOHN F. K | AIR |
| 76 | Nov 2025 | LIFESTAR PHARMA LLC | United States | Tablet | 1.2K | NOS | $10.80 | $13K | DELHI AIR | NEW YORK - JOHN F. K | AIR |
| 77 | Dec 2025 | LIFESTAR PHARMA LLC | United States | Tablet | 1.2K | NOS | $11.12 | $13K | DELHI AIR | NEW YORK - JOHN F. K | AIR |
| 78 | Dec 2025 | LIFESTAR PHARMA LLC | United States | Tablet | 1.2K | NOS | $11.12 | $13K | DELHI AIR | NEW YORK - JOHN F. K | AIR |
| 79 | Dec 2025 | LIFESTAR PHARMA LLC | United States | Tablet | 1.2K | NOS | $11.35 | $13K | DELHI AIR | NEW YORK - JOHN F. K | AIR |
| 80 | Dec 2025 | LIFESTAR PHARMA LLC | United States | Tablet | 1.2K | NOS | $11.35 | $13K | DELHI AIR | NEW YORK - JOHN F. K | AIR |
| 81 | Dec 2025 | LIFESTAR PHARMA LLC | United States | Tablet | 1.2M | NOS | $0.0094 | $11K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 82 | Dec 2025 | LIFESTAR PHARMA LLC | United States | Tablet | 1.2M | NOS | $0.0094 | $11K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| SUPPLIER #9 — MICRO LABS LTD · 2 shipments · $94K | |||||||||||
| 83 | Nov 2025 | UPS HEALTHCARE LOGISTICS & | United States | Suspension | 23.9K | PCS | $1.47 | $35K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 84 | Dec 2025 | UPS HEALTHCARE LOGISTICS & | United States | Suspension | 49.4K | PCS | $1.19 | $59K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| SUPPLIER #10 — ALKEM LABORATORIES LTD · 3 shipments · $91K | |||||||||||
| 85 | Nov 2025 | ASCEND LABORATORIES LLC | United States | Suspension | 24.2K | NOS | $1.26 | $31K | DELHI AIR | WASHINGTON, DULLES I | AIR |
| 86 | Nov 2025 | UNKNOWN BUYER | United States | Suspension | 24.2K | NOS | $1.26 | $31K | DELHI AIR | WASHINGTON, DULLES I | AIR |
| 87 | Nov 2025 | ASCEND LABORATORIES LLC | United States | Suspension | 24.1K | NOS | $1.24 | $30K | DELHI AIR | WASHINGTON, DULLES I | AIR |
| SUPPLIER #11 — VKT PHARMA PVT LTD · 3 shipments · $90K | |||||||||||
| 88 | Oct 2025 | GRANULES USA | United States | Tablet | 2.7M | NOS | $0.0066 | $18K | HYDERABAD ICD | NEWARK APT/NEW YORK | ICD |
| 89 | Nov 2025 | UNLISTED BUYER | United States | Tablet | 49.7K | NOS | $0.789 | $39K | NHAVA SHEVA SEA (JNPT) | Newark Apt/New York | SEA |
| 90 | Nov 2025 | UNLISTED BUYER | United States | Tablet | 10.0K | NOS | $3.29 | $33K | NHAVA SHEVA SEA (JNPT) | Newark Apt/New York | SEA |
| SUPPLIER #12 — MSN LABORATORIES PVT LTD · 10 shipments · $83K | |||||||||||
| 91 | Oct 2025 | NOVADOZ PHARMACEUTICALS LLC | United States | Tablet | 1.6K | NOS | $3.94 | $6K | THIMMAPUR ICD | SAVANNAH | ICD |
| 92 | Oct 2025 | NOVADOZ PHARMACEUTICALS LLC | United States | Tablet | 11.0K | NOS | $0.726 | $8K | THIMMAPUR ICD | SAVANNAH | ICD |
| 93 | Oct 2025 | NOVADOZ PHARMACEUTICALS LLC | United States | Tablet | 1.1M | NOS | $0.013 | $15K | HYDERABAD AIR | CHICAGO, IL | AIR |
| 94 | Oct 2025 | NOVADOZ PHARMACEUTICALS LLC | United States | Tablet | 1.1M | NOS | $0.013 | $15K | HYDERABAD AIR | CHICAGO, IL | AIR |
| 95 | Oct 2025 | NOVADOZ PHARMACEUTICALS LLC | United States | Tablet | 504.0K | NOS | $0.019 | $10K | HYDERABAD AIR | CHICAGO, IL | AIR |
| 96 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 2.2K | NOS | $4.10 | $9K | HYDERABAD ICD | SAVANNAH | ICD |
| 97 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 1.3K | NOS | $4.11 | $5K | HYDERABAD ICD | SAVANNAH | ICD |
| 98 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 2.1K | NOS | $4.12 | $9K | HYDERABAD ICD | SAVANNAH | ICD |
| 99 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 408 | NOS | $6.79 | $3K | HYDERABAD ICD | SAVANNAH | ICD |
| 100 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 480 | NOS | $7.35 | $4K | HYDERABAD ICD | SAVANNAH | ICD |
| SUPPLIER #13 — MEDOPHARM PVT LTD · 4 shipments · $56K | |||||||||||
| 101 | Nov 2025 | BLESSINGS INTERNATIONAL | United States | Tablet | 990 | NOS | $14.17 | $14K | KAMARAJAR PORT SEA | Houston | SEA |
| 102 | Nov 2025 | BLESSINGS INTERNATIONAL | United States | Tablet | 990 | NOS | $14.17 | $14K | KAMARAJAR PORT SEA | Houston | SEA |
| 103 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 990 | NOS | $14.17 | $14K | KAMARAJAR PORT SEA | Houston | SEA |
| 104 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 990 | NOS | $14.17 | $14K | KAMARAJAR PORT SEA | Houston | SEA |
| SUPPLIER #14 — AMNEAL PHARMACEUTICALS PVT LTD · 3 shipments · $55K | |||||||||||
| 105 | Nov 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Suspension | 12.9K | NOS | $2.06 | $27K | MUNDRA SEA | Savannah | SEA |
| 106 | Dec 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Suspension | 12.9K | NOS | $2.19 | $28K | MUNDRA SEA | Savannah | SEA |
| 107 | Dec 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Suspension | 12.9K | NOS | $0.025 | $320.54 | MUNDRA SEA | Savannah | AIR |
| SUPPLIER #15 — MARKSANS PHARMA LTD · 8 shipments · $46K | |||||||||||
| 108 | Oct 2025 | TIME-CAP LABS INC | United States | Tablet | 10.7K | NOS | $0.570 | $6K | NHAVA SHEVA SEA (JNPT) | New York | SEA |
| 109 | Oct 2025 | TIME-CAP LABS INC | United States | Tablet | 3.2K | NOS | $0.955 | $3K | NHAVA SHEVA SEA (JNPT) | New York | SEA |
| 110 | Nov 2025 | TIME-CAP LABS INC | United States | Tablet | 16.6K | NOS | $0.372 | $6K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 111 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 16.6K | NOS | $0.372 | $6K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 112 | Nov 2025 | TIME-CAP LABS INC | United States | Tablet | 28.2K | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 113 | Nov 2025 | TIME-CAP LABS INC | United States | Tablet | 28.2K | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 114 | Nov 2025 | TIME-CAP LABS INC | United States | Tablet | 28.2K | NOS | $0.569 | $16K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 115 | Dec 2025 | TIME-CAP LABS INC | United States | Tablet | 20.0K | NOS | $0.428 | $9K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| SUPPLIER #16 — WINDLAS BIOTECH LTD · 5 shipments · $10K | |||||||||||
| 116 | Nov 2025 | JAMP PHARMA CORP | Canada | Tablet | 5.1K | NOS | $0.290 | $1K | DELHI AIR | Montreal-Doraval Apt | AIR |
| 117 | Nov 2025 | JAMP PHARMA CORP | Canada | Tablet | 5.1K | NOS | $0.559 | $3K | DELHI AIR | Montreal-Doraval Apt | AIR |
| 118 | Nov 2025 | JAMP PHARMA CORP | Canada | Tablet | 1.3K | NOS | $0.290 | $371.66 | DELHI AIR | Montreal-Doraval Apt | AIR |
| 119 | Nov 2025 | JAMP PHARMA CORP | Canada | Tablet | 3.8K | NOS | $0.290 | $1K | DELHI AIR | Montreal-Doraval Apt | AIR |
| 120 | Nov 2025 | JAMP PHARMA CORP | Canada | Tablet | 15.1K | NOS | $0.290 | $4K | DELHI AIR | Montreal-Doraval Apt | AIR |
| SUPPLIER #17 — VL TRADELINK PVT LTD · 1 shipments · $26.52 | |||||||||||
| 121 | Dec 2025 | KAN ONYEMA | United States | Tablet | 13 | NOS | $2.04 | $26.52 | MUMBAI AIR (SAHAR) | NEW YORK | AIR |
| SUPPLIER #18 — VEA IMPEX (I) PVT LTD · 1 shipments · $2.02 | |||||||||||
| 122 | Dec 2025 | UNLISTED BUYER | Dominica | Tablet | 18 | NOS | $0.112 | $2.02 | MUMBAI AIR (SAHAR) | DOMINICA | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
1 countries · 3 shipments · $74K · 1 Indian suppliers · 1 buyers
SHIPMENTS
3
USD
$74K
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 1 destination countries in Oceania
1
Australia (100.0%)
$74K
Top 1 Indian suppliers into Oceania
1
CADILA PHARMACEUTICALS LTD
$74K
Top 1 Oceania importers
1
ARROW PHARMACEUTICALS PTY LTD · Australia
$74K
Top 1 dosage forms
1
Tablet
$74K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $41K | $21K |
| Nov | 0 | $0.0000 | — |
| Dec | 1 | $32K | $32K |
Shipment register · 3 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — CADILA PHARMACEUTICALS LTD · 3 shipments · $74K | |||||||||||
| 1 | Oct 2025 | ARROW PHARMACEUTICALS PTY LTD | Australia | Tablet | 864.0K | NOS | $0.036 | $31K | MUNDRA SEA | SYDNEY | SEA |
| 2 | Oct 2025 | ARROW PHARMACEUTICALS PTY LTD | Australia | Tablet | 282.9K | NOS | $0.036 | $10K | MUNDRA SEA | SYDNEY | SEA |
| 3 | Dec 2025 | ARROW PHARMACEUTICALS PTY LTD | Australia | Tablet | 1.4M | NOS | $0.023 | $32K | MUNDRA SEA | Sydney | SEA |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 49 Indian famotidine exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped famotidine in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | ALEMBIC PHARMACEUTICALS LTD | GUJARAT | 26 | $1.18M | Tablet | Americas |
| 2 | MYLAN LABORATORIES LTD | BANGALORE | 17 | $578K | Injection | Americas |
| 3 | ANNORA PHARMA PVT LTD | SANGAREDY DISTRICT | 18 | $409K | Tablet, Solution, Suspension | Americas |
| 4 | THRIVE THERAPEUTIC PVT LTD | THANE | 2 | $214K | Tablet | Asia |
| 5 | DRREDDYS LABORATORIES LTD | MEDCHEL MALKAJGIRI DIST | 4 | $211K | Tablet | Americas |
| 6 | MEDREICH LTD | BENGALURU | 3 | $207K | Tablet | Asia |
| 7 | MAIVA PHARMA PVT LTD | BANGALORE | 4 | $199K | Injection | Americas |
| 8 | WALLACE PHARMACEUTICALS PVT LTD | SOLAN | 2 | $188K | Tablet | Americas |
| 9 | MEDOPHARM | CHENNAI | 4 | $124K | Tablet | Asia |
| 10 | LUPIN LTD | MUMBAI | 3 | $102K | Suspension | Americas |
| 11 | UNISON PHARMACEUTICALS PVT LTD | AHMEDABAD | 1 | $100K | Tablet | Europe |
| 12 | MANKIND PHARMA LTD | HIMANCHAL PRADESH | 8 | $99K | Tablet | Americas |
| 13 | MICRO LABS LTD | VERNA | 2 | $94K | Suspension | Americas |
| 14 | ALKEM LABORATORIES LTD | VILLAGE-THANA | 3 | $91K | Suspension | Americas |
| 15 | VKT PHARMA PVT LTD | HYDERABAD | 3 | $90K | Tablet | Americas |
| 16 | MSN LABORATORIES PVT LTD | HYDERABAD | 10 | $83K | Tablet | Americas |
| 17 | CADILA PHARMACEUTICALS LTD | AHMEDABAD | 3 | $74K | Tablet | Oceania |
| 18 | MEDOPHARM PVT LTD | CHENNAI TAMILNADU | 4 | $56K | Tablet | Americas |
| 19 | AMNEAL PHARMACEUTICALS PVT LTD | RAJODA | 3 | $55K | Suspension | Americas |
| 20 | MARKSANS PHARMA LTD | MUMBAI | 8 | $46K | Tablet | Americas |
| 21 | OCEAN PHARMACEUTICAL | VADODARA | 4 | $32K | Injection | Europe |
| 22 | RATNATRIS PHARMACEUTICALS PVT LTD | AHMEDABAD | 1 | $24K | Injection | Africa |
| 23 | AJANTA PHARMA LTD | MUMBAI | 1 | $23K | Tablet | Europe |
| 24 | VINDHYA INTERNATIONAL | GANDHINAGAR | 3 | $21K | Injection | Europe |
| 25 | LABORATE PHARMACEUTICALS INDIA LTD | HIMANCHAL PRADESH | 2 | $13K | Tablet | Asia |
| 26 | PROTECH BIO SYSTEMS PVT LTD | GURUGRAM | 2 | $11K | Tablet | Asia |
| 27 | SHALINA LABORATORIES PVT LTD | MUMBAI | 1 | $10K | Tablet | Africa |
| 28 | WINDLAS BIOTECH LTD | DEHRADUN | 5 | $10K | Tablet | Americas |
| 29 | ASHISH MEDICAMENTS LLP | AMBALA CANTT | 2 | $7K | Tablet | Asia |
| 30 | PROTECH TELELINKS | KALA AMB | 1 | $5K | Injection | Asia |
| 31 | ARBRO PHARMACEUTICALS PVT LTD | NEW DELHI | 2 | $4K | Tablet | Asia |
| 32 | NOVATRA PHARMA PLC | N/A | 1 | $3K | Tablet | Asia |
| 33 | PHARMAX INDIA PVT LTD | MUMBAI | 1 | $2K | Injection | Africa |
| 34 | D VIJAY PHARMA PVT LTD | MUMBAI | 2 | $1K | Tablet | Africa |
| 35 | SUN PHARMACEUTICAL INDUSTRIES LTD | MUMBAI | 1 | $1K | Tablet | Asia |
| 36 | CIAN HEALTHCARE LTD | ROORKEE | 2 | $323.49 | Tablet | Asia |
| 37 | SANITAS MEDTECH INSTITUTE PVT LTD | Narhen | 1 | $300.35 | Tablet | Asia |
| 38 | CURETON BIOTECH PVT LTD | HARIDWAR | 2 | $271.71 | Tablet | Asia |
| 39 | SAVA HEALTHCARE LTD | PUNE | 10 | $218.25 | Tablet | Africa |
| 40 | CHOUDHARI IMPEX | CHENNAI | 4 | $212.55 | Gel, Tablet | Africa |
| 41 | HLL LIFECARE LTD | UTTAR PRADESH | 1 | $199.66 | Tablet | Africa |
| 42 | GET EXPORTS & IMPORTS SHOP | KANYAKUMARI DISTRICT | 1 | $128.29 | Gel | Asia |
| 43 | 3S PHARMACEUTICALS INDIA PVT LTD | MUMBAI | 1 | $104.94 | Tablet | Africa |
| 44 | DERRIC WOOD | SUBHASH PLACE | 59 | $66.03 | Tablet | Asia |
| 45 | CHEMSELECT PVT LTD | THIRUVANANTHAPURAM | 1 | $51.61 | Gel | Africa |
| 46 | VL TRADELINK PVT LTD | NAGPUR | 1 | $26.52 | Tablet | Americas |
| 47 | MEDMALL PHARMACY PVT LTD | HYDERABAD | 2 | $8.27 | Tablet | Africa |
| 48 | VEA IMPEX (I) PVT LTD | MUMBAI | 1 | $2.02 | Tablet | Americas |
| 49 | MILAN LABORATORIES (INDIA) PVT LTD | LTD KAMOTHE PANVEL NAVI MUMBAI | 3 | $0.0000 | Europe |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 49 global famotidine importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian famotidine in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | J. KNIPPER & COMPANY | United States | 22 | $987K | ALEMBIC PHARMACEUTIC… | Tablet |
| 2 | MYLAN INSTITUTIONAL INC | United States | 17 | $578K | MYLAN LABORATORIES LTD | Injection |
| 3 | MEIJI SEIKA PHARMATECH CO LTD | Japan | 3 | $207K | MEDREICH LTD | Tablet |
| 4 | SEVEN PHARMA LTDA | Costa Rica | 2 | $188K | WALLACE PHARMACEUTIC… | Tablet |
| 5 | REED-LANE INC | United States | 2 | $147K | DRREDDYS LABORATORIE… | Tablet |
| 6 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | 2 | $104K | MAIVA PHARMA PVT LTD | Injection |
| 7 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | 3 | $102K | LUPIN LTD | Suspension |
| 8 | ALISSA HEALTHCARE RESEARCH LTD | United Kingdom | 1 | $100K | UNISON PHARMACEUTICA… | Tablet |
| 9 | LIFESTAR PHARMA LLC | United States | 8 | $99K | MANKIND PHARMA LTD | Tablet |
| 10 | EVERSANA LIFESCIENCE SERVICES | United States | 2 | $94K | MAIVA PHARMA PVT LTD | Injection |
| 11 | UPS HEALTHCARE LOGISTICS & | United States | 2 | $94K | MICRO LABS LTD | Suspension |
| 12 | J.KNIPPER & COMPANY | United States | 2 | $86K | ALEMBIC PHARMACEUTIC… | Tablet |
| 13 | ARROW PHARMACEUTICALS PTY LTD | Australia | 3 | $74K | CADILA PHARMACEUTICA… | Tablet |
| 14 | DR REDDYS LABORATORIES INC | United States | 2 | $64K | DRREDDYS LABORATORIE… | Tablet |
| 15 | ASCEND LABORATORIES LLC | United States | 2 | $61K | ALKEM LABORATORIES LTD | Suspension |
| 16 | AMNEAL PHARMACEUTICALS LLC | United States | 3 | $55K | AMNEAL PHARMACEUTICA… | Suspension |
| 17 | WORLD HEALTH ORGANIZATION | Israel | 1 | $54K | MEDOPHARM | Tablet |
| 18 | NOVADOZ PHARMACEUTICALS LLC | United States | 5 | $54K | MSN LABORATORIES PVT… | Tablet |
| 19 | CAMBER PHARMACEUTICALS INC | United States | 3 | $44K | ANNORA PHARMA PVT LTD | Solution, Tablet |
| 20 | TIME-CAP LABS INC | United States | 7 | $40K | MARKSANS PHARMA LTD | Tablet |
| 21 | GALINOS FARM DOO ILINDEN | North Macedonia | 4 | $32K | OCEAN PHARMACEUTICAL | Injection |
| 22 | BLESSINGS INTERNATIONAL | United States | 2 | $28K | MEDOPHARM PVT LTD | Tablet |
| 23 | PLANET PHARMA SA | France | 1 | $23K | AJANTA PHARMA LTD | Tablet |
| 24 | SEVEN PHARMA CHILE SPA | Chile | 1 | $22K | ANNORA PHARMA PVT LTD | Tablet |
| 25 | GRANULES USA | United States | 1 | $18K | VKT PHARMA PVT LTD | Tablet |
| 26 | U.N.R.W.A | Lebanon | 1 | $13K | MEDOPHARM | Tablet |
| 27 | NAHEB HAMZA LTD | Afghanistan | 2 | $11K | PROTECH BIO SYSTEMS … | Tablet |
| 28 | PHARMA ASSOCIATES | Sri Lanka | 1 | $11K | LABORATE PHARMACEUTI… | Tablet |
| 29 | MEDAF PHARMACY SURLCENTRAL AFRICAN | Cameroon | 1 | $10K | SHALINA LABORATORIES… | Tablet |
| 30 | JAMP PHARMA CORP | Canada | 5 | $10K | WINDLAS BIOTECH LTD | Tablet |
| 31 | CAMBER CONSUMER CARE INC | United States | 2 | $9K | ANNORA PHARMA PVT LTD | Tablet |
| 32 | SAGLYK E.S | Turkmenistan | 1 | $5K | PROTECH TELELINKS | Injection |
| 33 | IMOCO EXPRESS SERVICE ULUSL NAKL | Turkey | 1 | $4K | ASHISH MEDICAMENTS LLP | |
| 34 | ALARIS LANKA (PVT) LTD | Sri Lanka | 1 | $3K | MEDOPHARM | Tablet |
| 35 | RAHMAN WALI LTD | Afghanistan | 1 | $2K | ARBRO PHARMACEUTICAL… | Tablet |
| 36 | UNIQUE PHARMA | DR Congo | 1 | $2K | PHARMAX INDIA PVT LTD | Injection |
| 37 | MUSBAH TASNIM TRADING LTD | Afghanistan | 1 | $2K | ARBRO PHARMACEUTICAL… | Tablet |
| 38 | HEALTHCARE CARE AGENCY | Seychelles | 2 | $1K | D VIJAY PHARMA PVT LTD | Tablet |
| 39 | MAIN PHARMACY ASSOCIATION, MINISTRY | Turkmenistan | 2 | $323.49 | CIAN HEALTHCARE LTD | Tablet |
| 40 | SUCCESS INTER LINK PTE LTD | Singapore | 1 | $300.35 | SANITAS MEDTECH INST… | Tablet |
| 41 | MUKBARAK HASHIMI LTD | Afghanistan | 2 | $271.71 | CURETON BIOTECH PVT … | Tablet |
| 42 | REGENCY EXIM TRADE LTD | Mauritius | 10 | $218.25 | SAVA HEALTHCARE LTD | Tablet |
| 43 | MINISTRY OF HEALTH | Seychelles | 1 | $199.66 | HLL LIFECARE LTD | Tablet |
| 44 | MAZI CHEMIST | Maldives | 1 | $128.29 | GET EXPORTS & IMPORT… | Gel |
| 45 | FOR THE ORDER OF | Mauritius | 1 | $104.94 | 3S PHARMACEUTICALS I… | Tablet |
| 46 | EMIRATES POST COMPANY | United Arab Emirates | 50 | $57.82 | DERRIC WOOD | Tablet |
| 47 | CAREWELL PHARMACY (PTY)LTD | Seychelles | 1 | $51.61 | CHEMSELECT PVT LTD | Gel |
| 48 | KAN ONYEMA | United States | 1 | $26.52 | VL TRADELINK PVT LTD | Tablet |
| 49 | PRISM INTERNATIONAL LLC | Seychelles | 2 | $8.27 | MEDMALL PHARMACY PVT… | Tablet |
This report covers 246 2025-Q4 Famotidine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/famotidine
Talk to our trade analyst
Need a custom famotidine report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/famotidine
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Famotidine product page
Live data, supplier directory, price trends, and trade route analysis